Open to everyone in the profession, Congress '24 will include over 130 hours of CPD across 32 different modules covering topics such as advanced diabetes, dermatology, nursing clinics, EDI and more.
The programme format caters to a variety of learning styles, from lectures and panel discussions to interactive sessions and free CPD workshops.
There'll be over 120 exhibitors in three commercial exhibition, offering insights into some of the latest industry innovations, from pharmaceuticals to cutting-edge equipment.
Andy Green, Chair of the Congress Committee said: "We know it's a significant commitment for individuals to give up one to three days, plus travel time, to join us, and we don't just aim to educate; we want our attendees to enjoy the experience.
"Our aspiration is not just to meet their expectations but to exceed them.
"The veterinary profession faces challenges, but we have so much to celebrate, and what better place to come together with many like-minded individuals to remind yourself why you wanted to be in this profession in the first place."
Early bird registration is open until 31st January, and prices start at £93 +VAT for BSAVA members for a one-day pass.
www.bsavacongress.com
An international group of scientists has published new results that herald a breakthrough in finding a vaccine against the most commonly diagnosed infectious disease of horses, strangles.
UK experts from the Animal Health Trust collaborated with scientists from the Swedish University of Agricultural Sciences (SLU), the Karonlinska Institutet Medical University and Intervacc AB, on the project - the results of which could benefit humans as well as animals.
Professor Andrew Waller, Head of Bacteriology at the AHT, said: "We have been working towards developing a vaccine for 7 years, and finally it seems as if all the hard work is paying off. We've already developed better ways of diagnosing exposure to the infection, and now, with the success of creating a safe and effective vaccine, it looks as if we're finally bringing together the tools necessary to eradicate this terrible disease."
The vaccine consists of seven different Streptococcus proteins and results from early tests published in PLoS Pathogens have been incredibly positive showing a high level of protection and no side effects. It is hoped that the strangles vaccine could be commercially available in the near future.
Streptococcus equi, the bacterium that causes strangles, shares 80 per cent identity with Streptococcus pyogenes - the leading cause of bacterial pharyngitis, tonsillitis and rheumatic fever in humans, which kills thousands of people each year. Scientists hope that the knowledge gained through developing the strangles vaccine will also help in developing vaccines to combat these human conditions.
Research leader, Professor Bengt Guss of SLU, said: "This is a most exciting project, where research is generating new applications and knowledge that can be used to develop vaccines against these important bacteria. This is particularly important considering the increased number of infectious diseases caused by antibiotic-resistant bacteria."
The vaccine development work was only made possible thanks to information from the Streptococcus equi genome sequencing project funded by The Horse Trust.
The Horse Trust's Chief Executive Brigadier Paul Jepson, said: "We are absolutely delighted that by pulling apart the genome of this plague of the horse world scientists have generated a truly safe and effective strangles vaccine. That this work could also benefit other animal and human health is beyond our wildest hopes."
Full text of the research findings can be found in PLoS Pathogens online at http://www.plospathogens.org/article/info%3Adoi%2F10.1371%2Fjournal.ppat.1000584
Congratulations to VetSurgeon members Mike Martin, Malcolm Ness and Mark Patteson, who were amongst the winners of the 2010 BSAVA Annual Awards.
Mike Martin actually collected two awards this year: The Dunkin Award for the author of the most valuable article published in the Journal of Small Animal Practice (Canine dilated cardiomyopathy: a retrospective study of signalment, presentation and clinical findings in 369 cases), and the Blaine Award presented by Royal Canin for outstanding contributions to the advancement of small animal medicine or surgery.
Malcolm Ness won the Simon Award for outstanding contributions in the field of veterinary surgery.
Mark Patteson picked up the Melton Award, presented annually by Royal Canin for meritorious contributions by veterinary surgeons to small animal veterinary practice.
Other winners included Iona Mathieson (Frank Beattie Travel Scholarship), Anne Vaughan-Thomas (deceased) (Amoroso Award), David Church (Woodrow Award), Luke Gamble (J.A. Wright Memorial Award), Olaf Reinhard Schaaf (Petsavers Award) and Steve Withrow (Bourgelat Award).
BCF Technology has launched the portable 9020HF Orange x-ray generator from Eco Ray.
BCF says the 9020HF is ideal for equine and large animal applications because it is is just marginally heavier than the 8016HF generator, but more powerful, allowing it to achieve excellent images of regions such as the stifle and spine.
The new BCF Clinical Development Manager and in-house vet Kimberly Palgrave said: "This new generator really fills the gap in the range and is an ideal balance between weight and power. It is also bright orange so impossible to miss when tidying the kit away in the yard."
BCF is also the sole official distributor in the UK and Ireland for Eco Ray generators.
To see the full range of X-ray generators and other X-ray and ultrasound equipment available from BCF visit http://www.bcftechnology.com/ or call +44 (0)1506 460023.
The RCVS is seeking the views of veterinary surgeons, veterinary nurses and members of the public about proposals for a new Royal Charter which would clarify and underpin the role of the College and give it formal recognition as regulator of the veterinary nursing profession.
The new Charter, approved at a meeting of RCVS Council in November, would replace the 1967 Supplemental Charter, with the most far reaching change being a proposal to make veterinary nursing a formally regulated profession on a similar footing to veterinary surgeons. Veterinary nurses would become associates of the College and have the post-nominal letters RVN. The List and the Register of Veterinary Nurses would also be effectively combined, meaning that the 1,100 listed veterinary nurses would join the 10,500 already on the Register.
Under the proposals registered veterinary nurses would continue to need to fulfil certain responsibilities, including abiding by the Code of Professional Conduct and completing an average of 15 hours a year of continuing professional development, and would be subject to RCVS disciplinary procedures.
What's new is that individuals struck off from the Register for serious professional misconduct would no longer be able to give medical treatment or carry out minor surgery under veterinary direction.
As well as changes to the regulation of veterinary nursing, the proposed Charter would also more clearly state the role and remit of the RCVS, for example, in advancing standards through the promotion of continuing professional development and the Practice Standards Scheme.
Professor Stephen May, a member of RCVS Council who led the Legislation Working Party that developed the new Charter proposals, said: "The proposed new Charter represents an historic opportunity to affirm the role of the RCVS, and to provide a modern framework for the future regulation of the professions. I call on veterinary surgeons and nurses, together with other interested stakeholders, to read the consultation documents and support our proposals."
Speaking about the need for change, RCVS President Neil Smith added: "The consultation paper explains why it is time to replace the 1967 Charter with a new version which sets out the role of the College. The present Charter doesn't explain what objects the RCVS should set out to achieve, and it is silent about veterinary nurses. The remit of the College should include being the regulator for the veterinary nursing profession, and we want a new Charter to recognise registered veterinary nurses.
"We hope that the new Charter will provide a solid basis for the work of the College for years to come. We would urge members of the professions and the public to let us know what they think and help us to make sure that we have got it right."
The consultation paper, which contains further details about the proposed Charter, is available to download at www.rcvs.org.uk/consultations. Those who wish to have their say must respond to b.myring@rcvs.org.uk with their comments by Friday 7 February 2014.
The RCVS will also be organising a meeting and a webinar during the consultation period for those who wish to ask questions about the proposals. Those interested in attending a meeting should email b.myring@rcvs.org.uk. The webinar will be held early in 2014 - further details will be on www.rcvs.org.uk in due course.
Dan (MRCVS) & Kirsty (RVN) Forster, the husband and wife team behind Isle of Wight-based The Mobile Vet are celebrating a Queen's Award for Enterprise.
The Mobile Vet offers a mobile service in custom-designed vehicles and also has a fully-equipped surgery based in Newport where further consultations, operations and diagnostics can be performed, giving clients the option to choose between a home visit or a more traditional form of veterinary care for their pets.
News of the award landed on their doormat recently, in a letter saying: "I am delighted to inform you that Her Majesty The Queen has been graciously pleased to approve the Prime Minister's recommendation that your organisation should receive a Queen's Award for Enterprise in Innovation this year."
The Queen announced the winners of the awards as part of her 90th birthday celebrations yesterday, and Kirsty & Dan have been invited to Buckingham Palace to meet her at an official reception in July.
Dan said: "We have been fortunate enough to receive excellent feedback from our clients since starting our business & enjoy an immense amount of job satisfaction with the way we work. A nod from Her Majesty is truly the crowning glory for our business. It just goes to show what can be achieved with exceptional hard work and effort, the love & support of family/friends & a formidable staff. This award is for all these people that help to make our business great!
"We are very much looking forward to meeting the Queen and can't quite get our heads round it. Kirsty has spent hours looking for a dress and I am brushing up on my royal etiquette!"
239 members took part in the survey, 46% from independent practices and the remainder in corporates.
60% were clinical directors, partners or owners and 30% were in an assistant or associate role.
Other than COVID, the main barriers to providing EMS were not having enough time or energy to support a student (approx 46%), too much work to do (approx 37%), not enough veterinary staff (approx 33%), and not having housing for a student (approx 19%).
The top four things which respondents felt would improve the quality of EMS were a clearer understanding of students' needs (92%), longer placements to allow more confidence to build (84%), free training on how to coach students (78%) and more resources to help students and mentors (73%).
It was also suggested that because universities are effectively asking vets to do their job for them, they should be offering free CPD to help all vets deliver EMS effectively.
To enhance the EMS experience, SPVS has produced a pre-placement preparation form which outlines the practice requirements, an EMS induction form to help students consider their priorities and expectations for the placement and the a Skills Matrix which provides a framework to structure learning objectives and record progress.
For the full survey report and to access the resources, visit the SPVS website https://spvs.org.uk/ems-free-resources-gateway/
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
The new clinic is led by Marie Kubiak, an RCVS Specialist and diplomate in Zoo and Wildlife Medicine and one of only a small number Specialists that are accredited for reptiles, birds, pet mammals, wildlife, zoo species, fish and invertebrates.
The open day offers a chance to see the new clinic, meet the team, find out how it can support your practice and discuss any challenging cases you have.
Light snacks and drinks will be provided.
RSVP: evolutionexoticsreferrals@gmail.com
https://evolutionexoticsreferrals.co.uk
Evolution Exotics Referrals, Tenbury Road, Cleobury Mortimer, South Shropshire, DY14 0AD
The Company of Animals, makers of behaviour and training products, has announced the launch of a new Product and Training DVD, designed to be screened in practice waiting rooms. The DVD features the entire range of products from Company of Animals, including its multi-award-winning dog training devices, being demonstrated by pet dogs and their owners. It is presented by Animal Psychologist and founder of The Company of Animals, Dr. Roger Mugford. The Company of Animals says that playing the DVD during opening hours will grab the attention of your customers, raise their awareness of already popular products, and educate them about new ones. This DVD is free and available to all veterinary retailers. To order the DVD or for more information see: http://www.companyofanimals.co.uk/
Sanofi-aventis and Merck & Co., Inc. announced today that Sanofi-aventis has exercised its option to combine Merial with Intervet/Schering-Plough, Merck's Animal Health business.
The new joint venture will be equally-owned by Merck and Sanofi-aventis. The formation of this new joint venture is subject to execution of final agreements, antitrust review in the United States, Europe and other countries, and other customary closing conditions. The completion of the transaction is expected to occur in approximately the next 12 months.
Richard T. Clark, Merck Chairman, President and Chief Executive Officer said: "Merck has been in the animal health business for well over six decades and through this new joint venture, we will bolster our diverse portfolio and create a new global competitor poised for growth.
"This new joint venture delivers on Merck's commitment to customer focus by creating one of the broadest portfolios of animal health products and services in pharmaceuticals and biologics for millions of customers who include farmers, veterinarians and pet owners. The planned joint venture will have an attractive geographical network of global technology and expertise to provide health solutions based on customers' needs, which often vary regionally."
The worldwide animal health market reached $19 billion in 2008. Products for companion animals accounted for 40 percent of total sales while products for production animals accounted for the remaining 60 percent of total sales. This market is expected to grow at around 5 percent per year over the next 5 years, driven by a growing demand for animal proteins, as well as a strong consumer needs for companion animal health care.
The companies said that both Merial and Intervet/Schering-Plough will continue to operate independently until the closing of the transaction.
Companion Care Vets has been named as one of The Sunday Times 100 Best Companies To Work For, the first veterinary organisation to receive the accolade.
Companion Care, which has 90 surgeries across the UK (the majority within Pets at Home stores) launched its joint venture partner model in 2001. The group received a "first class" one-star status from The Sunday Times, and was ranked at number 69 overall, a position determined by employee views, staff policies, processes and services.
Best Companies Accreditation is based around employee engagement and listed companies are noted for "excelling in every area throughout the workplace." Particularly recognised is an organisation's commitment to its most important assets - its workforce.
Jane Balmain, Managing Director of Companion Care Vets said: "We value every member of our team who have all worked tirelessly over the past 11 years to help our expansion into the market leader we are today. Without the commitment and expertise of every person within the organisation this would not have been possible and for us to receive this recognition, and on our first try, is outstanding."
Jane added: "To be the first veterinary organisation to receive Best Companies Accreditation is an honour and we will strive to continue to provide an exceptional working environment for our teams."
As part of the survey process 79% of Companion Care Vets' employees said their jobs are good for personal growth, 76% felt their jobs were secure and a fantastic 81% said colleagues are committed to taking care of each other.
With 109 Joint Veterinary Partners and a further 867 employees in the group, Companion Care Vets is one of the largest veterinary employers in the UK. The company plans to have 200 surgeries in place by 2015 which will create a host of career opportunities for vets and veterinary support teams around the UK.
Dechra Veterinary Products is offering CPD sessions as podcasts for the first time, as part of a new series of presentations on canine hyperadrenocorticism.
The Cushing's Challenge series, which will also be available as webcasts with supporting notes, is designed to challenge vets to update their knowledge on the syndrome.
There will be six presentations released on the company's online learning resource, The Dechra Academy, starting this month.
Dechra Veterinary Products Brand Manager, Craig Sankey said: "Although Cushing's is a common canine endocrinopathy, it can be challenging to diagnose and can mimic non-adrenal disorders. Test results can also sometimes be inconclusive which is why we've developed this series of CPD sessions to support veterinary professionals who want to update their knowledge.
"The Cushing's Challenge series will be the first time Dechra has used podcasts to deliver CPD, which can be downloaded and listened to on any MP3 player. They can also be viewed on a PC or tablet as a webcast with each of the presentations varying in length, from around 12 to 25 minutes long. By offering the presentations in both of these formats, we are able to offer flexible support to help busy veterinary professionals with CPD.
"The first episodes will focus on pathophysiology, clinical signs and routine lab tests with successive presentations released in the coming weeks. The next two in the series will cover diagnostic tests and then differentiation tests."
CPD certificates will be available at the end of the series via email.
The free-of-charge CPD is accompanied by client support materials for practices as part of Dechra's new Vetoryl campaign.
The Cushing's Challenge CPD is available at www.dechra.co.uk/academy,
MSD Animal Health has reintroduced Zanil, the flukicide drench for cattle and sheep.
Based on the active ingredient oxyclozanide, MSD says Zanil is highly effective against the adult fluke responsible for chronic disease and - significantly for dairy farmers - is licensed for use in young, pregnant and lactating animals, with a 72-hour milk withhold period where milk is produced for human consumption.
MSD Animal Health veterinary advisor Matt Haslam said: "The latest independent data1 confirms that fluke is on the increase in UK cattle and sheep. The fluke problem is longstanding, but is being exacerbated by recent wet summer and autumn periods that have created ideal conditions for this parasite to proliferate and infect grazing livestock.
"Chronic liver fluke causes serious economic losses for livestock farmers. In dairy herds, for example, there will be a negative impact on fertility and milk production where cows are affected.
"It is important that farmers have access to the best treatment options given the size of the threat and the scale of potential losses. Zanil is used widely and effectively in Ireland in the control of fluke problems, and there is no known resistance to the active ingredient oxyclozanide. With its re-introduction into the country, we believe Zanil is unique as a flukicide-only treatment that is licensed for use in lactation and in the dry period for the treatment of adult fluke in dairy cows."
Zanil is an oral drench with POM-VPS authorisation, available from both animal health suppliers and veterinary practices. Dosage rate is 3ml per 10kg bodyweight in cattle, up to a maximum of 105ml, and 4.5ml per 10kg bodyweight in sheep, up to a maximum of 20ml.
Reference
See DEFRA emerging threats reports in sheep and cattle, Q1 2013: www.defra.gov.uk/ahvla-en/files/pub-survrep-sr0113.pdf
It was the only organisation from the veterinary profession to be shortlisted.
The Antibiotic Guardian Awards were introduced this year by Public Health England (PHE) and aim to champion UK organisations and individuals who have demonstrated achievement in tackling antimicrobial resistance at a local, regional or national level.
BEVA first launched its Protect ME antimicrobial campaign in 2012 to coincide with European Antimicrobial Awareness day. The Association has launched additional resources each year to facilitate compliance and educate the public about the importance of antimicrobial awareness.
Mark Bowen, President of BEVA and co-author of the Protect ME toolkit, said: "It is a great achievement for a veterinary organisation to be recognised alongside the human health sector which invariably has significantly more resources to support antimicrobial stewardship. Protect ME has had a fantastic uptake from the equine profession and are proud of the impact that it is having. BEVA is grateful to all who have contributed to its success, especially Wendy Furness and Jacky Paton of the Scarsdale veterinary group, Derby who trialled it prior to launch and adopted it fully within the practice."
The BEVA Protect ME toolkit is free to BEVA members and can be downloaded at www.beva.org.uk.
The investment is being made to increase the speed at which concerns are either closed or referred, ensure that the process meets its service standards and reduce stress for the public and profession.
The decision to increase investment in the process was made by the College’s Operational Board in response to a steady increase in the number of concerns being investigated. The College forecasts that it will receive in excess of 1,000 concerns raised about the professional conduct of veterinary surgeons and veterinary nurses this year.
The RCVS developed a simplified, three-stage concerns process in 2014 which included the introduction of targets for cases to be either closed or referred at each stage. In order to ensure that these targets can be met, the College will now be hiring five paralegals to assist the existing five case managers.
Eleanor Ferguson, Acting Registrar, said: "Currently we are only closing or referring just over half of concerns we receive at stage 1 (case examiner stage) within our four month target. In order for the system to run more smoothly we will be investing in extra staff to help clear the backlog and ensure that these targets are met going forward.
"Similarly, in order to deal with the increase in the number of cases being referred to Preliminary Investigation Committee (stage 2), we will be increasing the frequency of these committee meetings from one to two per month.
"It is important to add that this investment is not just about dealing with concerns more quickly but is also about quality of service and having more staff on hand will ensure that this quality is maintained in terms of how we communicate with complainants and members of the profession. Speeding up the process will reduce the stress and anxiety felt by all involved."
More details about the College’s concerns investigation process and its different stages can be found at www.rcvs.org.uk/concerns
The survey is conducted every four to five years and asks vets to answer questions about a variety of subjects including demographic data (for example, socio-economic background, educational attainment, race/ethnicity, disability), work-related data (for example, employment status, location of workplace, type of workplace, hours of work, position in practice) and information about professional achievement (for example, hours of continuing professional development (CPD) undertaken and extra qualifications earned).
The survey, which is conducted on the College’s behalf by the Institute for Employment Studies, also ask respondents about their views on different aspects of their profession, including career plans, challenges facing the profession, and wellbeing.
This year, the survey also asks for your view of the RCVS, including its values, how it should communicate, and what it should prioritise in future years.
Lizzie Lockett, RCVS CEO (pictured right), said: "The results of the Surveys form a very important ‘snapshot’ of the profession at a given point in time, but they also prove useful for years to come in terms of how the College develops its regulatory and educational policy, the areas it chooses to focus on and the issues it chooses to tackle.
"The ensuing reports are also used by a myriad of other individuals, such as those in academia, government and representative bodies, as well as journalists. It’s therefore really important that we have as accurate a picture as possible. So although completing the Surveys is entirely voluntary, we strongly encourage members of the professions to take the time to complete them. It will, ultimately, help the development of appropriate and supportive policies for your profession."
In addition to the main survey, there will be an additional survey for MsRCVS who practise overseas. This survey aims to better understand why they continue to retain their MRCVS status, what this status means in the countries in which they work, global attitudes towards the RCVS and how the College could improve its communication with them.
The service will be headed by José C. Almansa Ruiz DVM (Hons) MSc (Vet) MRCVS.
José qualified from the Universidad Complutense de Madrid in 2008, before completing an honours degree in dentistry and maxillofacial surgery while working in an after-hours veterinary emergency hospital in Madrid.
In 2009, he relocated to South Africa where he undertook an internship in dentistry and maxillofacial surgery at the academic hospital of the faculty of veterinary science of the University of Pretoria. In 2011, he relocated to the UK and, in 2012, began the European Veterinary Dental College diploma.
In 2015, he returned to South Africa, working in referral hospitals, before being appointed as an extraordinary lecturer in veterinary dentistry and maxillofacial surgery at the Faculty of Veterinary Science of the University of Pretoria in January 2018.
This summer, José will sit the exams to become a European Specialist in Veterinary Dentistry.
Tim Richardson, managing director of both Southfields and Davies, said: “We look forward to welcoming José to the teams at both Southfields and Davies. He brings with him a wealth of experience and knowledge in his field and is a highly-respected clinician.
"The launch of dentistry and maxillofacial services at our multi-disciplinary referral centres is another exciting addition and we’re looking forward to accepting referrals from colleagues across the profession as we continue to lead the industry in the breadth of treatments that we can now offer.”
José said: “I’m delighted to be joining the teams at Southfields and Davies, and my plan is to establish and really grow a dentistry and maxillofacial surgery service over the coming 12 months.
“I would like to start offering reconstruction techniques for those patients undergoing mandibulectomies, while I have been hoping for some time now to begin using 3D printing as part of the planning for big surgeries.
“We will be offering a very complete and advanced veterinary dentistry service. From the maxillofacial surgery point of view, fracture repair procedures will see the introduction of non-invasive techniques for repair of maxillomandibular fractures.
“Craniofacial trauma cases will be worked up more in-depth together with anaesthesia, diagnostic imaging, ophthalmology, critical care and neurology, which will offer a truly multidisciplinary approach.”
For more information, visit www.southfields.co.uk or vetspecialists.co.uk.
To claim the free product, visit www.daxocox.co.uk/trial and use the stock selector to pick the dose sizes to suit the patients you think Daxocox could help.
Animalcare Marketing Manager James Beaumont explained: “When you consider that recent data shows that up to 20% of dogs over one year of age could have some form of OA1, the scale of problem becomes clear – as does the threat to the welfare of our canine companions from OA pain.
“Owners already giving Daxocox to their OA-affected pets, have seen first-hand how it can significantly improve their quality of life.
"90% said that their dog’s osteoarthritis improved, with 84% reporting that their dog’s quality of life improved from “poor or fair” to “good, very good or excellent.”2
James added: “In a study carried out by Animalare, 88% of owners said that weekly NSAID dosing would be easier to remember, or mean they were less likely to miss a dose or that it would control their dog’s pain more effectively.3
“Used as a first line treatment for OA, Daxocox can provide a solid foundation to long-term pain management that suits vets, dogs and their owners.
"As such, we’re confident that once practices have tried it, it will become their canine OA NSAID of choice.”
For more information, visit www.daxocox.co.uk
References
The VetCT teleconsulting service, which can be accessed via the web and an app-based platform, provides advice from a specialist team.
Typically advice is provided as a written report within 24 hours, with options for text chat or telephone conversations when vets may want to discuss the case with a specialist.
The service can be accessed on a pay-per-case or subscription basis.
Until now, follow-up advice had been capped at two weeks.
Internal medicine specialist and Head of Teleconsulting at VetCT, Kate Murphy, said: “We are delighted to be extending our support for cases that require ongoing management, such as endocrine disorders or complex wound management.
"Our clients have fed back how valuable it will be to partner with us longer term for these patients, to provide guidance and reassurance that care is being optimised and help to keep owners engaged and happy.”
welcome.vet-ct.com/sales
Ceva Animal Health has launched a new TV advertising campaign to raise awareness of the benefits of the veterinary behavioural product, Feliway.
The new advertisement, features the new 'Feliway' purple cat playing happily in the home with its family.
The advertisement will appear on the major UK channels including More 4, E4, ITV 1, Sky Channels and the Discovery Channel for one week from 16th September 2013, with an additional three weeks coverage during October 2013. Behind the scenes' footage of the filming of the advertisement can also be viewed on the Feliway YouTube Channel: http://www.youtube.com/channel/UCtAXd5mReYc6JGufxRirvng?feature=watch
A Feliway video on demand and YouTube campaign will be available to viewers between 16th September 2013 and 21st October 2013 and will be repeated between 15th November 2013 and 2nd December 2013.
An Adaptil video on demand campaign will be aired between 21st October 2013 and 11th November 2013 to raise awareness of Adaptil in the run up to and during the firework season. The video on demand will be available across ITV player, Sky Anytime On Demand, 4oD and YouTube.
For more information, call 01494 781510 or contact your local Ceva territory manager.
The RCVS has clarified its role concerning new UK veterinary schools, saying that it has no mandate to control student or graduate numbers.
Responding to calls from the profession that it should comment on the desirability of any change in the number of schools or graduates, the College has confirmed that whilst it is committed to setting, upholding and advancing the standards that any new UK veterinary degrees would need to meet in order to be approved by the Privy Council, it has no role in capping student numbers.
The College also points out that the free market and mobility of workers in the EU makes any control at the level of a sovereign state effectively meaningless with respect to workforce management. However, the College says it is committed to ensuring that standards are maintained, and to continue working with bodies such as the European Association of Establishments for Veterinary Education, which evaluates veterinary degrees across Europe.
The College also seeks to support healthy debate through providing information on the state of the profession - an example of which is the survey that it recently commissioned from the Institute for Employment Studies on job availability for veterinary graduates over the last five years.
The headline results from that survey were released in the summer, and showed that increasing graduate numbers over the last five years have so far appeared to have had little impact on veterinary job prospects, with 94% of graduate respondents seeking a role in clinical practice obtaining work within six months of starting to look.
The full RCVS Survey of Recent Graduates report is now available, and also shows that, of the 43% of veterinary surgeons who graduated in the last five years who responded:
The answers were analysed by year of graduation, veterinary school, age and gender, and the full report is available online at www.rcvs.org.uk/publications.
Orthomed has announced the launch of a series of four webinars covering a range of orthopaedic subjects.
The webinars are being presented by global diplomates and hosted by The Webinar Vet. They are:
Orthomed says the presentations are suitable for orthopaedic surgeons of all levels and interests, as well as those looking to get more involved in orthopaedic surgery.
The webinars are being held monthly, starting at the end of March.
The webinar series costs £97, which includes a £150 voucher to redeem against an Orthomed workshop.
In addition, the Webinar Vet has made 15 tickets available free of charge. To see if you can claim one, email Orthomed at info@orthomed.co.uk with the subject title Orthopaedic Webinar.
For more information, visit: https://www.thewebinarvet.com/orthopaedicexpertise
Founded in 1922, the practice has come a long way from the days when its founder, Tom Patterson did his rounds on a motorbike with a sidecar.
It's now a successful farm and small animal two branch practice with over 60 staff.
To celebrate its centenary, Shepton Vets published a book called '100 years of Shepton Vets' and held a large summer party.
In September, the practice will be holding a 100km fundraising cycle ride to raise money for the Farming Community Network charity.
The farm animal practice has also organised the ‘Tour de Yorkshire,’ a trip to visit three farms based in Yorkshire who are modernising and adapting their dairy businesses to be resilient and successful in the changing industry.
Senior director, Paddy Gordon, said: “Turning one hundred is important. We may have grown substantially but we haven’t lost the family and community feel. We want to bring our community, near and far along with us on this celebration.”
It may not be quite the same as a telegram from the Queen, but VetSurgeon.org wishes Shepton Vets a very Happy Birthday!
Intervet/Schering-Plough Animal Health has announced that it is re-introducing Equilis StrepE, the only strangles vaccine for horses in Europe. The vaccine was voluntarily withdrawn from the market in 2007 for stability reasons.
Equilis StrepE, which has already been relaunched in the Netherlands, is now scheduled to arrive in Italy in September and the United Kingdom in October this year. Further re-launches in European countries are scheduled later in 2010 and beyond.
According to Intervet/Schering-Plough, three years of additional research and development have resulted in several improvements to the vaccine, including a better manufacturing process to ensure that the product maintains its characteristics throughout its shelf-life. A more user-friendly applicator has been developed, which enables the needle to slot into place, thereby making it easier to administer the vaccine.
Equilis StrepE is administered through a submucosal injection in the upper lip of the horse and provides immunity for three months following two initial injections, four weeks apart. The vaccine significantly reduces clinical signs of strangles and occurrence of lymph node abscesses in horses that are at risk of infection.
Dr. Peter Daels, veterinarian at the Keros Insemination and Embryo Transfer Center in Beselare (Belgium) said: "In our recipient embryo transfer herd, we have used this strangles vaccine on over 500 mares. After a few applications, the vaccine was easy to administer and did not cause any serious side effects. Despite a steady flow of new horses, only eight cases of strangles were noted - all were mild and most were newly acquired horses that had apparently been exposed shortly before vaccination. I believe that the vaccine provided solid protection against the disease, reduced the severity of clinical cases and eliminated the risk of a widespread outbreak in our herd."
Dr. Roberto Ragni-Alunni, Global Technical Manager Equine at Intervet/Schering Plough Animal Health said: "The re-launch of Equilis StrepE in Europe is an important milestone in our efforts to fully meet the needs of our customers in the equine industry. We continue to work in a very intense and comprehensive way to ensure adequate supply of our equine vaccine range".